Cancer Therapeutics Innovation Pipeline
Tag
May 04, 2023
![Investment in Ontario drug discovery research will help develop new cancer medicines for patients](https://oicr.on.ca/wp-content/uploads/2023/05/CTIP_release.jpg)
Investment in Ontario drug discovery research will help develop new cancer medicines for patients
May 20, 2020
![Study points to common protein duo as a new therapeutic target for several cancer types](https://oicr.on.ca/wp-content/uploads/2020/05/RUVBL1.jpg)
Study points to common protein duo as a new therapeutic target for several cancer types
May 13, 2020
![Unexpected mitochondria activity in leukemia cells gives opening for new treatments](https://oicr.on.ca/wp-content/uploads/2020/05/mitochondria_NIH.jpg)
Unexpected mitochondria activity in leukemia cells gives opening for new treatments
Jul 24, 2019
![OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies](https://oicr.on.ca/wp-content/uploads/2019/07/CTIP.jpg)
OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies
Feb 21, 2019
![OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects](https://oicr.on.ca/wp-content/uploads/2021/11/oicr-logo-hyphen-inspired.jpg)
OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects
Jul 31, 2018
![Can an open drug discovery model find a solution for rare brain cancers in children?](https://oicr.on.ca/wp-content/uploads/2018/07/aled.jpg)
Can an open drug discovery model find a solution for rare brain cancers in children?
Dec 04, 2017
![OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic](https://oicr.on.ca/wp-content/uploads/2017/11/ctip-thumb.jpg)
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.